TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Buckman Laboratories AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
17,482
|
23,662
|
23,224 |
| Financial expenses |
705
|
82
|
281 |
| Earnings before taxes |
-919
|
637
|
750 |
| EBITDA |
-27
|
857
|
615 |
| Total assets |
8,200
|
10,129
|
10,278 |
| Current assets |
7,898
|
9,649
|
9,781 |
| Current liabilities |
6,772
|
7,711
|
7,671 |
| Equity capital |
1,428
|
2,418
|
2,607 |
| - share capital |
103
|
101
|
95 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
17.4%
|
23.9%
|
25.4% |
| Turnover per employee |
8,741
|
11,831
|
11,612 |
| Profit as a percentage of turnover |
-5.3%
|
2.7%
|
3.2% |
| Return on assets (ROA) |
-2.6%
|
7.1%
|
10.0% |
| Current ratio |
116.6%
|
125.1%
|
127.5% |
| Return on equity (ROE) |
-64.4%
|
26.3%
|
28.8% |
| Change turnover |
-6,608
|
-1,210
|
3,996 |
| Change turnover % |
-27%
|
-5%
|
21% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.